Metraipolis › archive › dc_ff31e5875d6e
Comparing the Impact of Tetrahydrocannabinol on 30-Day Readmission Rates and Hospital Length of Stay in Patients With Depression — Europe PMC PMID:42779162
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42779162
- DOI
- 10.1002/brb3.71792
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T07:59:13.771Z
- SHA-256 of the archived text
1273751db2448b02c2b09c01e78ef69f472c75006924ae0eda70fc6a0af2942b- Stable URL of this page
https://metraipolis.com/documento/dc_ff31e5875d6e
How to cite
Comparing the Impact of Tetrahydrocannabinol on 30-Day Readmission Rates and Hospital Length of Stay in Patients With Depression — Europe PMC PMID:42779162 — Europe PMC (en), https://europepmc.org/article/MED/42779162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff31e5875d6e (Metraipolis archive dc_ff31e5875d6e, sha256 1273751db2448b02c2b09c01e78ef69f472c75006924ae0eda70fc6a0af2942b)
BibTeX
@misc{dcff31e5875d6e,
title = {Comparing the Impact of Tetrahydrocannabinol on 30-Day Readmission Rates and Hospital Length of Stay in Patients With Depression — Europe PMC PMID:42779162},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42779162},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff31e5875d6e; sha256 1273751db2448b02c2b09c01e78ef69f472c75006924ae0eda70fc6a0af2942b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42779162. Agents can read the archived copy with the MCP tool read_document.